PatentsUSA
Biotechnology company Moderna has agreed to pay up to $2.25 billion to settle patent litigation over technology used in its COVID-19 vaccine, resolving a dispute with Arbutus Biop…
Biotechnology company Moderna has agreed to pay up to $2.25 billion to settle patent litigation over technology used in its COVID-19 vaccine, resolving a dispute with Arbutus Biopharma and Genevant Sciences. The lawsuits alleged that Moderna’s vaccine relied on patented lipid nanoparticle delivery systems, a technolog…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsUSA
High Court Upholds Lanham Act Name Clause, Clarifies Copyright Damages, and Considers Scope of Profits in Trademark Disputes
The U.S. Supreme Court concluded its 2023-24 term with significant decisions impacting intellectual property law, including a unanimous ruling on the Lanham Act’s name clause and a split decision on the timing of copyright damages. As the 2024-25 term begins, the Court has agreed to hear additional IP cases while decl…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsUSA
A year of pivotal court decisions, evolving litigation venues, and increased focus on technology-driven IP cases reshapes the U.S. intellectual property landscape.
The year 2024 proved transformative for U.S. intellectual property litigation, marked by steady case volumes, landmark Supreme Court and Federal Circuit decisions, and a surge in disputes involving artificial intelligence and trade secrets. Shifts in venue dynamics, the end of Chevron Deference, and the growing influe…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsUSA
Actavis Laboratories FL, Inc. secures key tax victory as court rules patent defense expenses are immediately deductible business costs
In a landmark decision, the Federal Circuit has ruled that generic pharmaceutical companies may deduct legal expenses incurred in defending Hatch-Waxman patent litigation as ordinary and necessary business expenses. The ruling, which affirms a lower court's decision in favor of Actavis Laboratories FL, Inc., clarifies…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsUSA
Actavis Laboratories secures key tax ruling affirming deductibility of Hatch-Waxman patent litigation expenses tied to ANDA filings
The U.S. Court of Appeals for the Federal Circuit has affirmed that generic drug manufacturers may immediately deduct patent litigation expenses incurred in connection with Abbreviated New Drug Application (ANDA) filings under the Hatch-Waxman Act. The decision, favoring Actavis Laboratories, clarifies that such litig…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsUSA
Western and Eastern Districts of Texas Remain Central to U.S. Patent Disputes Despite Changes in Case Assignment Procedures
Patent litigation in Texas experienced notable changes in 2022 following a judicial order that altered case assignment in the Western District. While filings in the Western District of Texas (WDTX) declined after the order, the drop was less severe than anticipated, and Judge Alan Albright continued to preside over a…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsUSA
Federal partnership aims to expand intellectual property education and innovation support across eight-state region
The University of Utah has entered into a formal agreement with the U.S. Patent and Trademark Office to host a new Mountain West Community Engagement Office. This initiative, part of the Unleashing American Innovators Act of 2022, is designed to provide intellectual property education, resources, and outreach to stude…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsUSA
Jury finds Yealink liable for patent infringement but rejects claims of willful misconduct and inducement; Yealink pursues further challenges to Barco’s US patents.
Barco has been awarded just over $907,000 in damages by a jury in the Eastern District of Texas after prevailing in a patent infringement case against Yealink concerning its ClickShare technology. The jury found Yealink liable for infringing six Barco patents through the sale of its WPP20 and WPP30 wireless presentati…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsUSA
Section 337 complaint targets major crystalline silicon panel makers, seeking broad exclusion of infringing TOPCon solar cells from U.S. market
First Solar has filed a Section 337 complaint with the U.S. International Trade Commission, alleging that ten leading solar panel manufacturers have infringed its patent covering tunnel oxide passivated contact (TOPCon) technology. The company seeks a general exclusion order to block imports of any TOPCon solar cells…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsUSA
The Tennessee-based EBOS company is hoping the second time is the charm in its efforts to stop Voltage, LLC from selling its trunk bus products in th…
The Tennessee-based EBOS company is hoping the second time is the charm in its efforts to stop Voltage, LLC from selling its trunk bus products in the U.S.
Wednesday, April 29, 2026
IIPLA News Desk
PatentsUSA
All Claims in Two Trina Solar Patents Invalidated Amid Broader International Patent Disputes
The United States Patent and Trademark Office has issued final written decisions invalidating all claims of two TOPCon solar cell patents previously asserted by Trina Solar against Canadian Solar subsidiaries. This development marks a significant turn in the ongoing legal battles between the two solar manufacturers, w…
Wednesday, April 29, 2026
IIPLA News Desk
